rufloxacin has been researched along with mf 5137 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Calistri, A; Cecchetti, V; Filipponi, E; Fravolini, A; Gatto, B; Moro, S; Palu', G; Palumbo, M; Parolin, C; Pecere, T; Tabarrini, O | 1 |
| Cecchetti, V; Fravolini, A; Pagella, PG; Tabarrini, O; Wise, R | 1 |
2 other study(ies) available for rufloxacin and mf 5137
| Article | Year |
|---|---|
6-Aminoquinolones as new potential anti-HIV agents.
Topics: Animals; Anti-HIV Agents; Cell Line; Chlorocebus aethiops; DNA, Viral; Herpesvirus 1, Human; HIV-1; Piperazines; Quinolones; Reverse Transcriptase Inhibitors; RNA, Viral; Spectrometry, Fluorescence; Structure-Activity Relationship; Vero Cells | 2000 |
In vitro activity of MF 5137, a new potent 6-aminoquinolone.
Topics: 4-Quinolones; Anti-Infective Agents; Bacteria; Ciprofloxacin; Culture Media; Fluoroquinolones; Isoquinolines; Microbial Sensitivity Tests; Quinolones | 1995 |